In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 37 for your search:
Drug:  motexafin gadolinium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Diagnostic, Screening
Status: Enrolling by invitation
Age: 50 to 75
Sponsor: Other
Protocol IDs: UMCU DENSE, ZONMW-200320002-UMCU, Pink Ribbon-10074, BSP-DENSE, DCS-UU-2009-4348, NCT01315015
2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000066627, PCI-P120-9801, MSKCC-00088, UCLA-9808021, NCI-V98-1470, NCT00003563
3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0302038, PCI-P-PCYC-0211, NCT00054795
4.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCI-P120-9501, NCI-V96-0844
5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01092, RTOG-0513, U10CA021661, CDR0000467802, NCT00305864
6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0223, NCT00290004
7.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 02H8, 1346001, NU-0228-024, PCI-P-PCYC-0213, NCT00089284
8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-01051, PCI-PCYC-0206, NCI-G01-1999, NCT00022256
9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0216, NCT00076401
10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0221, NCT00086034
11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0215, NCT00096837
12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0222, NCT00100711
13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0224, NCT00121420
14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0227, NCT00129844
15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0219, NCT00134186
16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and under at diagnosis
Sponsor: NCI
Protocol IDs: NCI-2012-01829, ACNS0222, U10CA098543, CDR0000504107, COG-ACNS0222, NCT00387790
17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0228, NCT00365183
18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0229, NCT00373204
19.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCI-P120-9401, NCI-V96-0841
20.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCLA-HSPC-970904203, COOPER-RP-97-126, LAC-USC-6G971, UCD-RW-98-01, UCLA-HSPC-970904201, UCLA-HSPC-970904202, NCI-T97-0108, NCT00003409, T97-0108
21.

Phase: Phase I
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCLA-HSPC-970904303, UCLA-HSPC-970904301, UCLA-HSPC-970904302, NCI-T97-0107, NCT00003410, T97-0107
22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066423, PCI-97-108, NCI-T97-0109, T97-0109, NCT00003411
23.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066941, J9840, P30CA006973, JHOC-98062407, NCI-T97-0115, T97-0115, NCT00003798
24.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NABTT-9712 CDR0000066986, P30CA006973, NABTT-9712, JHOC-NABTT-9712, NCT00006452
25.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-01845, COG-A09712, U01CA097452, CDR0000067087, CCG-09712, A09712, NCT00003909
1   
New Search